Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

Chongqing Precision Biotech Co., Ltd · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
leukemialymphoma
leukemia, b-cell, lymphoma, b-cell, car-t, cd19, cd22, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1046891
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.